PHASE II STUDY OF AMRUBICIN IN PATIENTS WITH REFRACTORY OR RESISTANT RELAPSED SMALL-CELL LUNG CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0901)

被引：0
|
作者：
Daga, H. [1 ]
Murakami, H.
Yamamoto, N. [6 ]
Shibata, T. [3 ]
Endo, M. [2 ]
Watanabe, H. [4 ]
Ichinose, Y. [5 ]
Yamamoto, N. [6 ]
Ohe, Y. [7 ]
Tamura, T. [6 ]
机构：
[1] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan
[2] Shizuoka Canc Ctr, Dept Radiol, Shizuoka, Japan
[3] Natl Canc Ctr, Regulatory Sci Sect, Multiinst Clin Trial Support Ctr, Tokyo, Japan
[4] Natl Canc Ctr, Dept Radiol, Tokyo, Japan
[5] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[6] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[7] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [1] A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)
    Murakami, Haruyasu
    Yamamoto, Nobuyuki
    Shibata, Taro
    Takeda, Koji
    Ichinose, Yukito
    Ohe, Yuichiro
    Yamamoto, Noboru
    Takeda, Yuichiro
    Kudoh, Shinzoh
    Atagi, Shinji
    Satouchi, Miyako
    Kiura, Katsuyuki
    Nogami, Naoyuki
    Endo, Masahiro
    Watanabe, Hirokazu
    Tamura, Tomohide
    LUNG CANCER, 2014, 84 (01) : 67 - 72
  • [2] Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic oncology research group study 0301
    Onoda, Sayaka
    Masuda, Noriyuki
    Seto, Takashi
    Eguchi, Kenji
    Takiguchi, Yuichi
    Isobe, Hiroshi
    Okamoto, Hiroaki
    Ogura, Takashi
    Yokoyama, Akira
    Seki, Nobuhiko
    Asaka-Amano, Yoshiko
    Harada, Masao
    Tagawa, Akihiro
    Kunikane, Hiroshi
    Yokoba, Masanori
    Uematsu, Kazutsugu
    Kuriyama, Takayuki
    Kuroiwa, Yumi
    Watanabe, Koshiro
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5448 - 5453
  • [3] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
  • [4] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
  • [5] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
    Hirose, T.
    Shirai, T.
    Kusumoto, S.
    Sugiyama, T.
    Yamaoka, T.
    Okuda, K.
    Ohmori, T.
    Ohnishi, T.
    Adachi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase II study of amrubicin, a new active drug in refractory or relapsed small-cell lung cancer (SCLC): Thoracic Oncology Research Group Trial 0301.
    Seto, T.
    Masuda, N.
    Takiguchi, Y.
    Isobe, H.
    Okamoto, H.
    Ogura, T.
    Yokoyama, A.
    Watanabe, K.
    Eguchi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [7] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [8] A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
    Kim, Yu-Jung
    Keam, Bhumsuk
    Ock, Chan-Young
    Song, Sanghoon
    Kim, Miso
    Kim, Se Hyun
    Kim, Ki Hwan
    Kim, Jin-Soo
    Kim, Tae Min
    Kim, Dong-Wan
    Lee, Jong Seok
    Heo, Dae Seog
    LUNG CANCER, 2019, 136 : 122 - 128
  • [9] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405
    Inoue, A.
    Ishimoto, O.
    Fukumoto, S.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Kanbe, M.
    Ogura, S.
    Harada, T.
    Oizumi, S.
    Harada, M.
    Sugawara, S.
    Fukuhara, T.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 800 - 803
  • [10] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
12345